Drug Information

Drug General Information
Drug ID
D0H3VK
Former ID
DNCL002479
Drug Name
BIIB 028
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 1 [547870]
Company
Biogen Idec
Target and Pathway
Target(s) Heat shock protein HSP90 Target Info Inhibitor [532433]
References
Ref 547870Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020039)
Ref 532433Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors. Clin Cancer Res. 2013 Sep 1;19(17):4824-31.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.